138 related articles for article (PubMed ID: 35098701)
21. Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer.
Wen L; Zhong G; Ren M
Sci Rep; 2022 Jan; 12(1):1032. PubMed ID: 35058550
[TBL] [Abstract][Full Text] [Related]
22. Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer.
Dholakia J; Llamocca E; Quick A; Salani R; Felix AS
Gynecol Oncol; 2020 Jun; 157(3):716-722. PubMed ID: 32217002
[TBL] [Abstract][Full Text] [Related]
23. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
24. The genetic epidemiology of second primary breast cancer.
Bernstein JL; Thompson WD; Risch N; Holford TR
Am J Epidemiol; 1992 Oct; 136(8):937-48. PubMed ID: 1456270
[TBL] [Abstract][Full Text] [Related]
25. Distribution of second primary malignancies suggests a bidirectional effect between breast and endometrial cancer: a population-based study.
Cortesi L; De Matteis E; Rashid I; Cirilli C; Proietto M; Rivasi F; Federico M
Int J Gynecol Cancer; 2009 Nov; 19(8):1358-63. PubMed ID: 20009890
[TBL] [Abstract][Full Text] [Related]
26. Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.
Adams SV; Ahnen DJ; Baron JA; Campbell PT; Gallinger S; Grady WM; LeMarchand L; Lindor NM; Potter JD; Newcomb PA
World J Gastroenterol; 2013 Jun; 19(21):3241-8. PubMed ID: 23745025
[TBL] [Abstract][Full Text] [Related]
27. Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population-based study.
Bao S; Jiang M; Wang X; Hua Y; Zeng T; Yang Y; Yang F; Yan X; Sun C; Yang M; Fu Z; Huang X; Li J; Wu H; Li W; Tang J; Yin Y
Cancer Med; 2021 Dec; 10(23):8662-8672. PubMed ID: 34643330
[TBL] [Abstract][Full Text] [Related]
28. Variation in type II endometrial cancer risk by Hispanic subpopulation: An exploratory analysis.
Schlumbrecht M; Baeker Bispo JA; Balise RR; Huang M; Slomovitz B; Kobetz E
Gynecol Oncol; 2017 Nov; 147(2):329-333. PubMed ID: 28888539
[TBL] [Abstract][Full Text] [Related]
29. Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study.
Zheng G; Sundquist J; Sundquist K; Ji J
BMC Cancer; 2021 Nov; 21(1):1210. PubMed ID: 34772394
[TBL] [Abstract][Full Text] [Related]
30. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
[TBL] [Abstract][Full Text] [Related]
31. Synchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand.
Tangjitgamol S; Khunnarong J; Srijaipracharoen S
J Gynecol Oncol; 2015 Oct; 26(4):293-302. PubMed ID: 26197770
[TBL] [Abstract][Full Text] [Related]
32. Body mass index, diabetes and survival after diagnosis of endometrial cancer: A report from the HUNT-Survey.
Lindemann K; Cvancarova M; Eskild A
Gynecol Oncol; 2015 Dec; 139(3):476-80. PubMed ID: 26434365
[TBL] [Abstract][Full Text] [Related]
33. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
[TBL] [Abstract][Full Text] [Related]
34. Mortality of lung cancer as a second primary malignancy: A population-based cohort study.
Deng L; Harðardottír H; Song H; Xiao Z; Jiang C; Wang Q; Valdimarsdóttir U; Cheng H; Loo BW; Lu D
Cancer Med; 2019 Jun; 8(6):3269-3277. PubMed ID: 30993899
[TBL] [Abstract][Full Text] [Related]
35. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
36. Better Prognosis and Survival in Esophageal Cancer Survivors After Comorbid Second Primary Malignancies: A SEER Database-Based Study.
Ye J; Hu S; Zhang W; Zhang D; Zhang Y; Yu D; Peng J; Xu J; Wei Y
Front Surg; 2022; 9():893429. PubMed ID: 35769151
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer screening in women with endometrial cancer: are we following the guidelines?
Singh MM; Singh E; Miller H; Strum WB; Coyle W
J Gastrointest Cancer; 2012 Jun; 43(2):190-5. PubMed ID: 21380941
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use.
Grzankowski KS; Szender JB; Spring-Robinson CL; Lele SB; Odunsi KO; Frederick PJ
Int J Gynecol Cancer; 2016 Oct; 26(8):1440-7. PubMed ID: 27648713
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for rural endometrial cancer patients in a population-based cohort.
Blackburn BE; Soisson S; Rowe K; Snyder J; Fraser A; Deshmukh V; Newman M; Smith K; Herget K; Kirchhoff AC; Kepka D; Werner TL; Gaffney D; Mooney K; Hashibe M
BMC Public Health; 2019 Jul; 19(1):921. PubMed ID: 31291920
[TBL] [Abstract][Full Text] [Related]
40. Pelvic inflammatory disease increases the risk of a second primary malignancy in patients with cervical cancer treated by surgery alone.
Chiou WY; Chen CA; Lee MS; Lin HY; Li CY; Su YC; Tsai SJ; Hung SK
Medicine (Baltimore); 2016 Nov; 95(47):e5409. PubMed ID: 27893679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
